The role of the brain renin–angiotensin system in hypertension: Implications for new treatment

Abhold, 1987, Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin, J. Pharmacol. Exp. Ther., 242, 957 Aguilera, 1982, Angiotensin II receptors and prolactin release in pituitary lactotrophs, Endocrinology, 111, 1045, 10.1210/endo-111-4-1045 Ahmad, 1990, Role of aminopeptidase A activity in the regulation of the pressor activity of circulating angiotensins, J. Pharmacol. Exp. Ther., 252, 643 Allen, 1992, Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia, Ann. Neurol., 32, 339, 10.1002/ana.410320306 Allen, 1992, Localization of angiotensin receptor binding sites in the rat brain, 1 Allen, 1999, Angiotensin II receptors in the human brain, Regul. Pept., 79, 1, 10.1016/S0167-0115(98)00138-4 Allen, 2000, Localization and function of angiotensin AT1 receptors, Am. J. Hypertens., 13, 31S, 10.1016/S0895-7061(99)00249-6 ALLHAT, 2002, Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), JAMA, 288, 2981, 10.1001/jama.288.23.2981 Alliot, 1999, Pericytes and periendothelial cells of brain parenchyma vessels co-express aminopeptidase N, aminopeptidase A, and nestin, J. Neurosci. Res., 58, 367, 10.1002/(SICI)1097-4547(19991101)58:3<367::AID-JNR2>3.0.CO;2-T Andresen, 2005, AT2 receptors cross talk with AT1 receptors through a nitric oxide- and RhoA-dependent mechanism resulting in decreased phospholipase D activity, Am. J. Physiol. Renal Physiol., 288, F763, 10.1152/ajprenal.00323.2004 Aronsson, 1988, Evidence for the existence of angiotensinogen mRNA in magnocellular paraventricular hypothalamic neurons, Acta Physiol. Scand., 132, 585, 10.1111/j.1748-1716.1988.tb08370.x Bakris, 1997, Role of vasopressin in essential hypertension: racial differences, J. Hypertens., 15, 545, 10.1097/00004872-199715050-00011 Bargmann, 1951, The site of origin of the hormones of the posterior pituitary, Am. Sci., 39, 255 Basso, 1981, Renin-like activity in the rat brain during the development of DOC-salt hypertension, Hypertension, 3, 14 Batt, 1988, Pressor responses to amastatin, bestatin and Plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran, Brain Res. Bull., 21, 731, 10.1016/0361-9230(88)90039-1 Benarroch, 2005, Paraventricular nucleus, stress response, and cardiovascular disease, Clin. Auton. Res., 15, 254, 10.1007/s10286-005-0290-7 Bodineau, 2008, Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension, Hypertension, 51, 1318, 10.1161/HYPERTENSIONAHA.107.098772 Bumpus, 1991, Angiotensin I and II. Some early observations made at The Cleveland Clinic Foundation and recent discoveries relative to angiotensin II formation in human heart, Hypertension, 18, 122 Bumpus, 1991, Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research, Hypertension, 17, 720, 10.1161/01.HYP.17.5.720 Bunnemann, 1992, The distribution of angiotensin II AT1 receptor subtype mRNA in the rat brain, Neurosci. Lett., 142, 155, 10.1016/0304-3940(92)90362-B Campbell, 1995, Angiotensin peptides in the brain, Adv. Exp. Med. Biol., 377, 349, 10.1007/978-1-4899-0952-7_24 Campbell, 1995, Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats, Hypertension, 25, 928, 10.1161/01.HYP.25.5.928 Caputo, 1995, Postnatal MSG treatment attenuates angiotensin II (AII) induced drinking in rats, Physiol. Behav., 58, 25, 10.1016/0031-9384(95)00031-D Chai, 1987, Distribution of angiotensin converting enzyme in sheep hypothalamus and medulla oblongata visualized by in vitro autoradiography, Clin. Exp. Hypertens. [A], 9, 449 Chapleau, 2004, Modulation of baroreflex function by altering inspiratory impedance: potential mechanisms and clinical implications, Clin. Auton. Res., 14, 217, 10.1007/s10286-004-0209-8 Chappell, 2007, Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1–7)-MAS receptor axis: more than regulation of blood pressure?, Hypertension, 50, 596, 10.1161/HYPERTENSIONAHA.106.076216 Chauvel, 1994, Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols, J. Med. Chem., 37, 2950, 10.1021/jm00044a016 Checler, 1993, Neuropeptide-degrading peptidases, 375 Colombari, 2001, Role of the medulla oblongata in hypertension, Hypertension, 38, 549, 10.1161/01.HYP.38.3.549 Conchon, 1994, Internalization of the rat AT1a and AT1b receptors: pharmacological and functional requirements, FEBS Lett., 349, 365, 10.1016/0014-5793(94)00703-9 Cook, 1990, Comparison of angiotensin metabolism by brain membranes from SHR and WKY rats, Brain Res., 529, 320, 10.1016/0006-8993(90)90844-2 Correa, 1992, Chemical lesion of the circumventricular organs with monosodium glutamate reduces the blood pressure of spontaneously hypertensive but not of one kidney-one clip hypertensive rats, Braz. J. Med. Biol. Res., 25, 515 Corvol, 1997, Molecular genetics of human hypertension: role of angiotensinogen, Endocr. Rev., 18, 662 Corvol, 2002, Angiotensin II receptor blockers: current status and future prospects, Drugs, 62, 53, 10.2165/00003495-200262991-00006 Culman, 2001, The renin–angiotensin system in the brain: an update, J. Renin Angiotensin Aldosterone Syst., 2, 96, 10.3317/jraas.2001.019 Czyzewski, 1973, Failure of feedback suppression of renin release in the spontaneously hypertensive rat, Am. J. Physiol., 225, 234, 10.1152/ajplegacy.1973.225.1.234 Dampney, 1994, Functionnal organization of central pathways regulating the cardiovascular system, Physiol. Rev., 74, 323, 10.1152/physrev.1994.74.2.323 Davisson, 1998, The brain renin–angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes, Circ. Res., 83, 1047, 10.1161/01.RES.83.10.1047 De Mota, 2008, Human brain aminopeptidase A: biochemical properties and distribution in brain nuclei, J. Neurochem., 106, 416, 10.1111/j.1471-4159.2008.05402.x de Gasparo, 2000, International union of pharmacology. XXIII. The angiotensin II receptors, Pharmacol. Rev., 52, 415 Deschepper, 1986, Colocalization of angiotensinogen and glial fibrillary acidic protein in astrocytes in rat brain, Brain Res., 374, 195, 10.1016/0006-8993(86)90411-7 Diz, 1986, Contribution of the vagus nerve to angiotensin II binding sites in the canine medulla, Brain Res. Bull., 17, 497, 10.1016/0361-9230(86)90217-0 Düsing, 2010, Optimizing blood pressure control through the use of fixed combinations, Vasc. Health Risk Manage., 6, 321, 10.2147/VHRM.S9989 Eguchi, 2003, Metalloprotease-dependent ErbB ligand shedding in mediating EGFR transactivation and vascular remodelling, Biochem. Soc. Trans., 31, 1198, 10.1042/bst0311198 Eguchi, 2000, Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase, Regul. Pept., 91, 13, 10.1016/S0167-0115(00)00126-9 Epstein, 1976, The physiology of thirst, Can. J. Physiol. Pharmacol., 54, 369, 10.1139/y76-090 Esler, 1995, Sympathetic nervous system: contribution to human hypertension and related cardiovascular diseases, J. Cardiovasc. Pharmacol., 26, S24, 10.1097/00005344-199506262-00004 Felix, 1978, Angiotensin receptive neurones in the subfornical organ. Structure-activity relations, Brain Res., 149, 107, 10.1016/0006-8993(78)90591-7 Feng, 2009, Angiotensin-converting enzyme 2: a new target for neurogenic hypertension, Exp. Physiol., 95, 601, 10.1113/expphysiol.2009.047407 Ferrario, 2006, Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation, Hypertension, 47, 515, 10.1161/01.HYP.0000196268.08909.fb Fournie-Zaluski, 1992, Potent and systemically active aminopeptidase N inhibitors designed from active site investigation, J. Med. Chem., 35, 1259, 10.1021/jm00085a013 Fournie-Zaluski, 2004, Brain renin–angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension, Proc. Natl. Acad. Sci. U.S.A., 101, 7775, 10.1073/pnas.0402312101 Fried, 1996, Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor therapy, Transfusion (Paris), 36, 900, 10.1046/j.1537-2995.1996.361097017177.x Ganten, 1978, The brain isorenin–angiotensin system: biochemistry, localization and possible role in drinking and blood pressure regulation, Frontiers in Neuroendocrinology, 5, 61 Ganten, 1983, Angiotensin synthesis in the brain and increased turnover in hypertensive rats, Science, 221, 869, 10.1126/science.6879184 Ganten, 1971, Angiotensin-forming enzyme in brain tissue, Science, 173, 64, 10.1126/science.173.3991.64 Gehlert, 1991, Autoradiographic localization of subtypes of angiotensin II antagonist binding in the rat brain, Neuroscience, 44, 501, 10.1016/0306-4522(91)90073-W Gehlert, 1986, Quantitative autoradiography of angiotensin II receptors in the SHR brain, Peptides, 7, 1021, 10.1016/0196-9781(86)90132-4 Griendling, 1997, Angiotensin II signaling in vascular smooth muscle. New concepts, Hypertension, 29, 366, 10.1161/01.HYP.29.1.366 Grobe, 2008, An intracellular renin–angiotensin system in neurons: fact, hypothesis, or fantasy, Physiology (Bethesda), 23, 187 Guilluy, 2008, Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation, Circ. Res., 102, 1265, 10.1161/CIRCRESAHA.107.164764 Gutkind, 1988, Increased concentration of angiotensin II binding sites in selected brain areas of spontaneously hypertensive rats, J. Hypertens., 6, 79, 10.1097/00004872-198801000-00012 Guyenet, 2006, The sympathetic control of blood pressure, Nat. Rev. Neurosci., 7, 335, 10.1038/nrn1902 Guyton, 1991, Blood pressure control—special role of the kidneys and body fluids, Science, 252, 1813, 10.1126/science.2063193 Harding, 1986, High-performance liquid chromatographic analysis of ‘specifically bound’ label after [125I]angiotensin II binding to rat brain membranes, Neurosci. Lett., 65, 23, 10.1016/0304-3940(86)90114-X Harding, 1987, Angiotensin-sensitive neurons in the rat paraventricular nucleus: relative potencies of angiotensin II and angiotensin III, Brain Res., 410, 130, 10.1016/S0006-8993(87)80033-1 Harding, 1987, The effects of aminopeptidase inhibitors amastatin and bestatin on angiotensin-evoked neuronal activity in rat brain, Brain Res., 424, 299, 10.1016/0006-8993(87)91474-0 Harding, 1992, Release of angiotensins in paraventricular nucleus of rat in response to physiological and chemical stimuli, Am. J. Physiol., 262, F17 Hatae, 1994, Comparative studies on species-specific reactivity between renin and angiotensinogen, Mol. Cell. Biochem., 131, 43, 10.1007/BF01075723 Healy, 1993, Localization of immunoreactive glutamyl aminopeptidase in rat brain. II. Distribution and correlation with angiotensin II, Brain Res., 606, 295, 10.1016/0006-8993(93)90997-2 Hein, 1995, Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice, Nature, 377, 744, 10.1038/377744a0 Hermann, 1987, Presence of renin in primary neuronal and glial cells from rat brain, Brain Res., 437, 205, 10.1016/0006-8993(87)91637-4 Hersh, 1987, Immunohistochemical localization of aminopeptidase M in rat brain and periphery: relationship of enzyme localization and enkephalin metabolism, Peptides, 8, 523, 10.1016/0196-9781(87)90019-2 Higuchi, 2007, Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology, Clin. Sci. (Lond.), 112, 417, 10.1042/CS20060342 Hoffman, 1978, Inhibition of drinking on water-deprived rats by combined central angiotensin II and cholinergic receptor blockade, Am. J. Physiol., 234, 41 Hogarty, 1992, The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin, Brain Res., 586, 289, 10.1016/0006-8993(92)91638-U Hohle, 1995, Angiotensin AT(1) receptor-mediated vasopressin release and drinking are potentiated by an AT(2) receptor antagonist, Eur. J. Pharmacol., 275, 277, 10.1016/0014-2999(95)00005-6 Holm, 1996, Brief report: acute renal failure after losartan treatment in a patient with bilateral renal artery stenosis, Blood Press., 5, 360, 10.3109/08037059609078075 Hunyady, 2001, Structural requirements for signalling and regulation of AT1 receptors, J. Renin Angiotensin Aldosteron Syst., 2, 16, 10.1177/14703203010020010301 Ichiki, 1995, Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor, Nature, 377, 10.1038/377748a0 Israili, 1992, Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology, Ann. Intern. Med., 117, 234, 10.7326/0003-4819-117-3-234 Ito, 2000, Pharmacological profile of depressor response elicited by sarthran in rat ventrolateral medulla, Am. J. Physiol. Heart Circ. Physiol., 279, 2961, 10.1152/ajpheart.2000.279.6.H2961 Jamerson, 2008, Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients, N. Engl. J. Med., 359, 2417, 10.1056/NEJMoa0806182 Johansen, 2001, Reversible renal impairment induced by treatment with the angiotensin II receptor antagonist candesartan in a patient with bilateral renal artery stenosis, BMC Nephrol., 2, 1, 10.1186/1471-2369-2-1 Johnson, 1996, Integrative role of the lamina terminalis in the regulation of cardiovascular and body fluid homeostasis, Clin. Exp. Pharmacol. Physiol., 23, 183, 10.1111/j.1440-1681.1996.tb02594.x Kambayashi, 1993, Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition, J. Biol. Chem., 268, 24543, 10.1016/S0021-9258(19)74499-8 Kearney, 2005, Global burden of hypertension: analysis of worldwide data, Lancet, 365, 217, 10.1016/S0140-6736(05)17741-1 Kokje, 2007, Central pressor actions of aminopeptidase-resistant angiotensin II analogs: challenging the angiotensin III hypothesis, Hypertension, 49, 1328, 10.1161/HYPERTENSIONAHA.107.087130 Kumar, 1988, Angiotensinogen gene expression in neuronal and glial cells in primary cultures of rat brain, J. Neurosci. Res., 19, 287, 10.1002/jnr.490190302 Lee, 1995, Impaired retention by angiotensin II mediated by the AT(1) receptor, Peptides, 16, 1069, 10.1016/0196-9781(95)00073-S Lee-Kirsch, 1999, Distinct renin isoforms generated by tissue specific transcription initiation and alternative splicing, Circ. Res., 84, 240, 10.1161/01.RES.84.2.240 Lenkei, 1995, The angiotensin receptor subtype AT1A predominates in rat forebrain areas involved in blood pressure, body fluid homeostasis and neuroendocrine control, Mol. Brain Res., 30, 53, 10.1016/0169-328X(94)00272-G Lenkei, 1999, Identification of endocrine cell populations expressing the AT1B subtype of angiotensin II receptors in the anterior pituitary, Endocrinology, 140, 472, 10.1210/endo.140.1.6397 Lenkei, 1996, Distribution of angiotensin II type-2 receptor (AT2) mRNA expression in the adult rat brain, J. Comp. Neurol., 373, 322, 10.1002/(SICI)1096-9861(19960923)373:3<322::AID-CNE2>3.0.CO;2-4 Lenkei, 1997, Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review, Front. Neuroendocrinol., 18, 383, 10.1006/frne.1997.0155 Lenkei, 1998, Distribution of angiotensin type-1 receptor (AT1) mRNA expression in the adult rat brain, Neuroscience, 82, 827, 10.1016/S0306-4522(97)00328-X Levine, 2003, Effect of amlodipine on systolic blood pressure, Clin. Ther., 25, 35, 10.1016/S0149-2918(03)90007-5 Lin, 1997, Involvement of AT2 receptors at NRVL in tonic baroreflex suppression by endogenous angiotensins, Am. J. Physiol., 272, H2204 Lind, 1990, Angiotensin, vol. 9, part II, 165 Lind, 1984, Angiotensin II immunoreactive pathways in the central nervous system of the rat: evidence for a projection from the subfornical organ to the paraventricular nucleus of the hypothalamus, Clin. Exp. Hypertens., A6, 1915 Lind, 1985, Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system: an immunohistochemical study, Neuroendocrinology, 40, 2, 10.1159/000124046 Lohmeier, 2001, The sympathetic nervous system and longterm blood pressure regulation, Am. J. Hypertens., 14, S147, 10.1016/S0895-7061(01)02082-9 MacGregor, 1995, Angiotensin II receptor subtypes in the human central nervous system, Brain Res., 675, 231, 10.1016/0006-8993(95)00076-3 Malfroy, 1989, Molecular cloning and amino acid sequence of rat kidney aminopeptidase M: a member of a super family of zinc-metallohydrolases, Biochem. Biophys. Res. Commun., 161, 236, 10.1016/0006-291X(89)91586-6 Mancia, 1995, Interactions between the sympathetic nervous system and the renin angiotensin system, vols. 1 and 2 Martin, 1995, A functional comparison of the rat type-1 angiotensin II receptors (AT1AR and AT1BR), Regul. Pept., 60, 135, 10.1016/0167-0115(95)00123-9 Masuyama, 1986, Peripheral neural mechanism of hypertension in rat models—peripheral sympathetic neurotransmission in hypertension, J. Hypertens. Suppl., 4, S189 Meng, 1994, Antisense oligonucleotide to AT1 receptor mRNA inhibits central angiotensin induced thirst and vasopressin, Regul. Pept., 54, 543, 10.1016/0167-0115(94)90551-7 Meyer, 1989, Levels of immunoreactive angiotensin II in microdissected nuclei from adult WKY and SH rat brain, Clin. Exp. Hypertens. [A], 11, 103 Min, 2008, Angiotensin II type 2 receptor deletion enhances vascular senescence by methyl methanesulfonate sensitive 2 inhibition, Hypertension, 51, 1339, 10.1161/HYPERTENSIONAHA.107.105692 Mitsui, 2003, Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice, Mol. Med., 9, 57, 10.1007/BF03402108 Morimoto, 2001, Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter, Circ. Res., 89, 365, 10.1161/hh1601.094988 Morimoto, 2002, Glia- and neuron-specific expression of the renin–angiotensin system in brain alters blood pressure, water intake, and salt preference, J. Biol. Chem., 277, 33235, 10.1074/jbc.M204309200 Morimoto, 2002, Neuron-specific expression of human angiotensinogen in brain causes increased salt appetite, Physiol. Genomics, 9, 113, 10.1152/physiolgenomics.00007.2002 Morton, 1979, Inhibitors of the renin–angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor, Br. J. Clin. Pharmacol., 7, S233, 10.1111/j.1365-2125.1979.tb04695.x Mukoyama, 1993, Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors, J. Biol. Chem., 268, 24539, 10.1016/S0021-9258(19)74498-6 Murphy, 1991, Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor, Nature, 351, 233, 10.1038/351233a0 Nakajima, 1993, Cloning of cDNA and analysis of the gene for mouse angiotensin II type 2 receptor, Biochem. Biophys. Res. Commun., 197, 393, 10.1006/bbrc.1993.2492 Naruse, 1985, Regional distribution of renin and angiotensinogen in the brain of normotensive (WKY) and spontaneously hypertensive (SHR) rats, Brain Res., 333, 147, 10.1016/0006-8993(85)90135-0 Nishimura, 1998, Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats, J. Hypertens., 16, 1175 Nouet, 2004, Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP, J. Biol. Chem., 279, 28989, 10.1074/jbc.M403880200 Nouet, 2000, Signal transduction from the angiotensin II AT2 receptor, Trends Endocrinol. Metab., 11, 1, 10.1016/S1043-2760(99)00205-2 Okuyama, 1999, Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor, Brain Res., 821, 150, 10.1016/S0006-8993(99)01098-7 Oparil, 1994, Role of anterior hypothalamic angiotensin II in the pathogenesis of salt sensitive hypertension in the spontaneously hypertensive rat, Am. J. Med. Sci., 307, S26 Owen, 1994, Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis, Transfusion (Paris), 34, 891, 10.1046/j.1537-2995.1994.341095026976.x Palkovits, 1995, Neurotransmitters and neuropeptides in the baroreceptor reflex arc: connections between the nucleus of the solitary tract and the ventrolateral medulla oblongata in the rat, Clin. Exp. Hypertens., 17, 101, 10.3109/10641969509087058 Palmieri, 1989, Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M, Biochem. Pharmacol., 38, 173, 10.1016/0006-2952(89)90165-2 Phillips, 1987, Functions of angiotensin in the central nervous system, Annu. Rev. Physiol., 49, 413, 10.1146/annurev.ph.49.030187.002213 Phillips, 1988, Brain angiotensin in the developing spontaneously hypertensive rat, J. Hypertens., 6, 607, 10.1097/00004872-198808000-00002 Porrello, 2009, The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor, Front. Biosci., 14, 958, 10.2741/3289 Radevski, 1999, Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension, Am. J. Hypertens., 12, 194, 10.1016/S0895-7061(98)00233-7 Reaux, 1999, PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III, Neuroendocrinology, 69, 370, 10.1159/000054439 Reaux, 1999, Aminopeptidase A inhibitors as potential central antihypertensive agents, Proc. Natl. Acad. Sci. U.S.A., 96, 13415, 10.1073/pnas.96.23.13415 Renaud, 1991, Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxytocin, Prog. Neurobiol., 36, 131, 10.1016/0301-0082(91)90020-2 Reudelhuber, 2005, The renin–angiotensin system: peptides and enzymes beyond angioensin II, Curr. Opin. Nephrol. Hypertens., 14, 155, 10.1097/00041552-200503000-00011 Rodrigues-Ferreira, 2010, An ATIPical family of angiotensin II AT2 receptor-interacting proteins, Trends Endocrinol. Metab., 21, 684, 10.1016/j.tem.2010.08.009 Rowe, 1990, Angiotensin II receptor subtypes in the rat brain, Eur. J. Pharmacol., 186, 339, 10.1016/0014-2999(90)90457-H Saavedra, 1992, Brain and pituitary angiotensin, Endocr. Rev., 13, 329, 10.1210/edrv-13-2-329 Saine, 1996, Renal impairment associated with losartan, Ann. Intern. Med., 124, 775, 10.7326/0003-4819-124-8-199604150-00015 Sakai, 2007, Local production of angiotensin II in the subfornical organ causes elevated drinking, J. Clin. Invest., 117, 1088, 10.1172/JCI31242 Sandberg, 1992, Cloning and expression of a novel angiotensin II receptor subtype, J. Biol. Chem., 267, 9455, 10.1016/S0021-9258(19)50109-0 Sasaki, 1991, Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor, Nature, 351, 230, 10.1038/351230a0 Sasamura, 1992, Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome, Biochem. Biophys. Res. Commun., 185, 253, 10.1016/S0006-291X(05)80983-0 Saunders, 1990, Drug therapy in pregnancy: the lessons of diethylstilbestrol, thalidomide, and bendectin, Health Care Women Int., 11, 423, 10.1080/07399339009515912 Schelling, 1982, A micromethod for the measurement of renin in brain nuclei: its application in spontaneously hypertensive rats, Neuropharmacology, 21, 455, 10.1016/0028-3908(82)90031-4 Schieffer, 1996, Importance of tyrosine phosphorylation in angiotensin II type 1 receptor signaling, Hypertension, 27, 476, 10.1161/01.HYP.27.3.476 Sinn, 2000, Identification of three human renin mRNA isoforms from alternative tissue-specific transcriptional initiation, Physiol. Genomics, 3, 25, 10.1152/physiolgenomics.2000.3.1.25 Smith, 2002, Treatment of hypertension with an angiotensin II-receptor antagonist compared with an angiotensin-converting enzyme inhibitor: a review of clinical studies of telmisartan and enalapril, Clin. Ther., 24, 1484, 10.1016/S0149-2918(02)80056-X Song, 1992, Mapping of angiotensin II receptor subtype heterogeneity in rat brain, J. Comp. Neurol., 316, 467, 10.1002/cne.903160407 Song, 1997, Aminopeptidase A antiserum inhibits intracerebroventricular angiotensin II-induced dipsogenic and pressor responses, Brain Res., 744, 1, 10.1016/S0006-8993(96)00952-3 Speck, 1981, In vivo activity of purified mouse brain renin, Brain Res., 219, 371, 10.1016/0006-8993(81)90300-0 Stornetta, 1988, Astrocytes synthesize angiotensinogen in brain, Science, 242, 1444, 10.1126/science.3201232 Suzuki, 2005, Recent progress in signal transduction research of the angiotensin II type-1 receptor: protein kinases, vascular dysfunction and structural requirement, Curr. Med. Chem. Cardiovasc. Hematol. Agents, 3, 305, 10.2174/156801605774322355 Swanson, 1983, Hypothalamic integration: organization of the paraventricular and supraoptic nuclei, Annu. Rev. Neurosci., 6, 269, 10.1146/annurev.ne.06.030183.001413 Thomas, 1992, Angiotensinogen is secreted by pure rat neuronal cell cultures, Brain Res., 588, 191, 10.1016/0006-8993(92)91575-Y Thomas, 1988, Immunocytochemical localization of angiotensinogen in the rat brain, Neuroscience, 25, 319, 10.1016/0306-4522(88)90029-2 Tieku, 1992, Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme, Biochem. Pharmacol., 44, 1725, 10.1016/0006-2952(92)90065-Q Troyanovskaya, 2000, Aminopeptidase-A. I. CDNA cloning and expression and localization in rat tissues, Am. J. Physiol. Regul. Integr. Comp. Physiol., 278, R413, 10.1152/ajpregu.2000.278.2.R413 Vazeux, 1996, Identification of glutamate residues essential for catalytic activity and zinc coordination in aminopeptidase A, J. Biol. Chem., 271, 9069, 10.1074/jbc.271.15.9069 Veerasingham, 2003, Brain renin–angiotensin system dysfunction in hypertension: recent advances and perspectives, Br. J. Pharmacol., 139, 191, 10.1038/sj.bjp.0705262 Veltmar, 1992, Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release, J. Pharmacol. Exp. Ther., 263, 1253 Wan, 2004, Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist, J. Med. Chem., 47, 5995, 10.1021/jm049715t Watanabe, 1999, Effects of targeted disruption of the mouse angiotensin II type 2 receptor gene on stress-induced hyperthermia, J. Physiol., 515, 881, 10.1111/j.1469-7793.1999.881ab.x Welch, 2008, Angiotensin II-dependent superoxide: effects on hypertension and vascular dysfunction, Hypertension, 52, 51, 10.1161/HYPERTENSIONAHA.107.090472 Wilk, 1993, Glutamyl aminopeptidase (aminopeptidase A), the BP-1/6C3 antigen, Adv. Neuroimmunol., 3, 195, 10.1016/S0960-5428(05)80021-X Wilson, 2005, Roles of brain angiotensins in thirst and sodium appetite, Brain Res., 1060, 108, 10.1016/j.brainres.2005.08.032 Wright, 1992, Regulatory role of brain angiotensins in the control of physiological and behavioral responses, Brain Res. Rev., 17, 227, 10.1016/0165-0173(92)90018-H Wright, 1994, Brain angiotensin receptor subtypes in the control of physiological and behavioral responses, Neurosci. Biobehav. Rev., 18, 21, 10.1016/0149-7634(94)90034-5 Wright, 1989, Leucine aminopeptidase M-induced reductions in blood pressure in spontaneously hypertensive rats, Hypertension, 13, 910, 10.1161/01.HYP.13.6.910 Wright, 1990, Aminopeptidase-induced elevation and reduction in blood pressure in the spontaneously hypertensive rat, J. Hypertens., 8, 969, 10.1097/00004872-199010000-00013 Wright, 1985, Pressor action and dipsogenicity induced by angiotensin II and III in rats, Am. J. Physiol., 249, R514 Wright, 1990, Intracerebroventricularly infused [D-Arg1]angiotensin III is superior to [D-Asp1]angiotensin II, as a pressor agent in rats, Brain Res., 514, 5, 10.1016/0006-8993(90)90428-E Wright, 2003, Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats, Am. J. Physiol. Regul. Integr. Comp. Physiol., 284, R725, 10.1152/ajpregu.00326.2002 Wright, 2008, Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets, Prog. Neurobiol., 84, 157, 10.1016/j.pneurobio.2007.10.009 Wu, 1990, Molecular cloning of the murine BP-1/6C3 antigen: a member of the zinc-dependent metallopeptidase family, Proc. Natl. Acad. Sci. U.S.A., 87, 993, 10.1073/pnas.87.3.993 Yamaguchi, 1979, A comparison between the effects of angiotensin II and angiotensin III injected into the third cerebral ventricle on vasopressin secretion in conscious rats (author's transl), Nippon Naibunpi Gakkai Zasshi, 55, 1286 Yamazato, 2007, Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats, Hypertension, 49, 926, 10.1161/01.HYP.0000259942.38108.20 Yang, 1992, Angiotensin II receptor activation depolarizes rat supraoptic neurons in vitro, Am. J. Physiol., 263, R1333 Yin, 2003, Angiotensin II signaling pathways mediated by tyrosine kinases, Int. J. Biochem. Cell Biol., 35, 780, 10.1016/S1357-2725(02)00300-X Yongue, 1991, Brain and liver angiotensinogen messenger RNA in genetic hypertensive and normotensive rats, Hypertension, 17, 485, 10.1161/01.HYP.17.4.485 Zini, 1998, Inhibition of vasopressinergic neurons by central injection of a specific aminopeptidase A inhibitor, Neuroreport, 9, 825, 10.1097/00001756-199803300-00011 Zini, 1996, Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release, Proc. Natl. Acad. Sci. U.S.A., 93, 11968, 10.1073/pnas.93.21.11968 Zini, 1997, Aminopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats, Neuroscience, 78, 1187, 10.1016/S0306-4522(96)00660-4